Iterum Therapeutics Plc (NASDAQ:ITRM) Long Term Investor Notice: Investigation of Potential Wrongdoing
An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Iterum Therapeutics plc.
View full press release